妊娠期血脂、甲状腺及凝血功能与妊娠期糖尿病发生风险的相关性分析
Association of Gestational Blood Lipids, Thyroid Function and Coagulation Function with the Risk of Gestational Diabetes Mellitus
DOI: 10.12677/acm.2025.15123627, PDF,   
作者: 徐小哲, 林曼霞, 刘帅, 旦慧文*:中国人民解放军海军第九七一医院妇产科,山东 青岛
关键词: 妊娠期糖尿病血脂甲状腺功能凝血功能Gestational Diabetes Mellitus Blood Lipids Thyroid Function Coagulation Function
摘要: 目的:通过系统比较GDM组和非GDM组孕妇妊娠期的血脂、凝血功能、甲状腺功能相关指标,鉴定GDM高危因素并建立预测模型,以期更早识别GDM孕妇。方法:回顾分析2022年1月至2023年12月在海军第九七一医院进行产前检查的797例孕妇,其中GDM组174例(21.8%),非GDM组623例(78.2%),比较两组孕妇血脂、凝血功能以及甲状腺功能相关指标的差异,并基于危险因素构建预测模型。结果:GDM组的总胆固醇、甘油三酯、脂蛋白(a)、载脂蛋白B、乳酸脱氢酶、D-二聚体、凝血酶原时间、三碘甲状腺原氨酸、促甲状腺素、BMI均显著高于非GDM组,而凝血酶时间、抗甲状腺球蛋白抗体、甲状腺过氧化物酶抗体显著低于非GDM组,差异均有统计学意义(P均<0.05)。二元Logistic回归分析结果显示:甘油三酯、载脂蛋白B、D-二聚体、三碘甲状腺原氨酸、促甲状腺素的升高为GDM发生的独立危险因素(OR > 1, P < 0.05)。受试者工作曲线(ROC)分析证实:甘油三酯预测AUC为0.791 (95% CI 0.756~0.826),载脂蛋白B预测AUC为0.589 (95% CI 0.539~0.64),D-二聚体预测AUC为0.536 (95% CI 0.485~0.587),三碘甲状腺原氨酸预测AUC为0.547 (95% CI 0.498~0.597),促甲状腺素预测AUC为0.468 (95% CI 0.421~0.515)。联合ROC分析结果显示AUC为0.825 (95% CI 0.792~0.858),其敏感度可达87.9%。结论:血脂代谢中甘油三酯、载脂蛋白B,甲状腺功能中三碘甲状腺原氨酸、促甲状腺素,以及凝血功能中D-二聚体共5项指标均为GDM发生的独立危险因素,联合预测模型AUC可达到0.825,其准确性和敏感度明显高于单因素模型。
Abstract: Objective: By systematically comparing the indicators of blood lipids, coagulation and thyroid function-related indices of pregnant women in the GDM group and the non-GDM group during pregnancy, we aim to identify the risk factors of GDM and establish a prediction model, to detect pregnant women with GDM earlier. Methods: We retrospectively collected clinical data of 797 pregnant women who received regular antenatal care at 971 Navy Hospital from January 2022 to December 2023, including 174 (21.8%) in the GDM group and 623 (78.2%) in the non-GDM group. The differences in blood lipids, coagulation function and thyroid function-related indices between the two groups were compared. The prediction model was constructed based on the identified risk factors. Results: Total cholesterol, triglyceride, lipoprotein(a), apolipoprotein B, lactate dehydrogenase, D-dimer, prothrombin time, triiodothyronine, thyrotropin and BMI in the GDM group were significantly higher than those in the non-GDM group, while thrombin time, anti-thyroglobulin antibody and thyroid peroxidase antibody were significantly lower than those in the non-GDM group. The differences were statistically significant (P < 0.05). Logistic regression analysis showed that the increase of triglyceride, apolipoprotein B, D-dimer, triiodothyronine and thyrotropin were independent risk factors for GDM (OR > 1, P < 0.05). Receiver Operating Curve (ROC) analysis revealed that the predictive AUC of triglyceride was 0.791 (95%CI 0.756~0.826), apolipoprotein B was 0.589 (95%CI 0.539~0.64), D-dimer was 0.536 (95%CI 0.485~0.587), triiodothyronine was 0.547 (95%CI 0.498~0.597), and thyrotropin was 0.468 (95%CI 0.421~0.515). Combined ROC analysis showed that the predictive AUC was 0.825 (95%CI 0.792~0.858) and the sensitivity was 87.9%. Conclusions: The five indices including triglyceride and apolipoprotein B in lipid metabolism, triiodothyronine and thyrotropin in thyroid function, and D-dimer in coagulation function were all independent risk factors for the occurrence of GDM. The AUC of the combined prediction model could reach 0.825, and the sensitivity and specificity of which were significantly higher than those of the single-factor model.
文章引用:徐小哲, 林曼霞, 刘帅, 旦慧文. 妊娠期血脂、甲状腺及凝血功能与妊娠期糖尿病发生风险的相关性分析[J]. 临床医学进展, 2025, 15(12): 2063-2071. https://doi.org/10.12677/acm.2025.15123627

参考文献

[1] Boriboonhirunsarn, D. and Kasempipatchai, V. (2016) Incidence of Large for Gestational Age Infants When Gestational Diabetes Mellitus Is Diagnosed Early and Late in Pregnancy. Journal of Obstetrics and Gynaecology Research, 42, 273-278. [Google Scholar] [CrossRef] [PubMed]
[2] Wang, H., Li, N., Chivese, T., Werfalli, M., Sun, H., Yuen, L., et al. (2022) IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Research and Clinical Practice, 183, Article 109050. [Google Scholar] [CrossRef] [PubMed]
[3] HAPO Study Cooperative Research Group, Metzger, B.E., Lowe, L.P., et al. (2008) Hyperglycemia and Adverse Pregnancy Outcomes. The New England Journal of Medicine, 358, 1991-2002.
[4] Abokaf, H., Shoham-Vardi, I., Sergienko, R., Landau, D. and Sheiner, E. (2018) In Utero Exposure to Gestational Diabetes Mellitus and Long Term Endocrine Morbidity of the Offspring. Diabetes Research and Clinical Practice, 144, 231-235. [Google Scholar] [CrossRef] [PubMed]
[5] Sellers, E.A.C., Dean, H.J., Shafer, L.A., Martens, P.J., Phillips-Beck, W., Heaman, M., et al. (2016) Exposure to Gestational Diabetes Mellitus: Impact on the Development of Early-Onset Type 2 Diabetes in Canadian First Nations and Non-First Nations Offspring. Diabetes Care, 39, 2240-2246. [Google Scholar] [CrossRef] [PubMed]
[6] Plows, J.F., Stanley, J.L., Baker, P.N., Reynolds, C.M. and Vickers, M.H. (2018) The Pathophysiology of Gestational Diabetes Mellitus. International Journal of Molecular Sciences, 19, Article 3342. [Google Scholar] [CrossRef] [PubMed]
[7] Li, S., Wang, W., Zhou, L., Ma, L., An, Y., Xu, W., et al. (2015) Fibroblast Growth Factor 21 Expressions in White Blood Cells and Sera of Patients with Gestational Diabetes Mellitus during Gestation and Postpartum. Endocrine, 48, 519-527. [Google Scholar] [CrossRef] [PubMed]
[8] Jia, X., Wang, S., Ma, N., Li, X., Guo, L., Liu, X., et al. (2015) Comparative Analysis of Vaspin in Pregnant Women with and without Gestational Diabetes Mellitus and Healthy Non-Pregnant Women. Endocrine, 48, 533-540. [Google Scholar] [CrossRef] [PubMed]
[9] International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger, B.E., Gabbe, S.G., et al. (2010) International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care, 33, 676-682. [Google Scholar] [CrossRef] [PubMed]
[10] Li, G., Kong, L., Zhang, L., Fan, L., Su, Y., Rose, J.C., et al. (2015) Early Pregnancy Maternal Lipid Profiles and the Risk of Gestational Diabetes Mellitus Stratified for Body Mass Index. Reproductive Sciences, 22, 712-717. [Google Scholar] [CrossRef] [PubMed]
[11] Liang, Z.X., Wu, Y., Zhu, X.Y., et al. (2016) Insulin Resistance and Lipid Profile during an Oral Glucose Tolerance Test in Women with and without Gestational Diabetes Mellitus. Journal of Obstetrics and Gynaecology, 36, 337-339. [Google Scholar] [CrossRef] [PubMed]
[12] 乔国昱, 何亚萍, 周洁. 妊娠期糖尿病并发甲状腺功能减退孕妇凝血功能指标的变化研究[J]. 现代检验医学杂志, 2017, 32(3): 109-111.
[13] Li, A., Hou, J., Fu, J., Wang, Y., Hu, Y., Zhuang, T., et al. (2023) Association between Serum Levels of TSH and Free T4 and Per-and Polyfluoroalkyl Compounds Concentrations in Pregnant Women. Journal of Environmental Sciences, 124, 11-18. [Google Scholar] [CrossRef] [PubMed]
[14] Konar, H., Sarkar, M. and Roy, M. (2018) Association of Thyroid Dysfunction and Autoimmunity in Pregnant Women with Diabetes Mellitus. The Journal of Obstetrics and Gynecology of India, 68, 283-288. [Google Scholar] [CrossRef] [PubMed]
[15] 魏小英, 杨琼. 妊娠期糖尿病患者凝血指标、D-二聚体检测及临床意义分析[J]. 中国妇幼健康研究, 2022, 33(2): 100-105.
[16] 李骏, 胡峥, 徐莺. 妊娠期妇女甲状腺功能异常与其营养指标、血脂变化及QT间期的相关性[J]. 中国计划生育学杂志, 2022, 30(10): 2374-2377.
[17] Coussa, A., Hasan, H.A. and Barber, T.M. (2021) Early Predictors of Gestational Diabetes Mellitus in IVF-Conceived Pregnancies. Endocrine Practice, 27, 579-585. [Google Scholar] [CrossRef] [PubMed]
[18] Barat, S., Batebi, Z., Bouzari, Z., et al. (2018) Triglyceride to HDL Cholesterol Ratio and Risk for Gestational Diabetes and Birth of a Large-for-Gestational-Age Newborn. Caspian Journal of Internal Medicine, 9, 368-375.
[19] Marseille-Tremblay, C., Ethier-Chiasson, M., Forest, J., Giguère, Y., Masse, A., Mounier, C., et al. (2008) Impact of Maternal Circulating Cholesterol and Gestational Diabetes Mellitus on Lipid Metabolism in Human Term Placenta. Molecular Reproduction and Development, 75, 1054-1062. [Google Scholar] [CrossRef] [PubMed]
[20] Rizzo, M., Berneis, K., Altinova, A.E., Toruner, F.B., Akturk, M., Ayvaz, G., et al. (2008) Atherogenic Lipoprotein Phenotype and LDL Size and Subclasses in Women with Gestational Diabetes. Diabetic Medicine, 25, 1406-1411. [Google Scholar] [CrossRef] [PubMed]
[21] 陈群. 孕中期脂代谢水平及血脂LDL/HDL、TG/HDL比值与妊娠期糖尿病的关系研究[J]. 黑龙江医药, 2023, 36(5): 1181-1183.
[22] Wang, D., Xu, S., Chen, H., Zhong, L. and Wang, Z. (2015) The Associations between Triglyceride to High-Density Lipoprotein Cholesterol Ratios and the Risks of Gestational Diabetes Mellitus and Large-for-Gestational-Age Infant. Clinical Endocrinology, 83, 490-497. [Google Scholar] [CrossRef] [PubMed]
[23] Hasain, Z., Mokhtar, N.M., Kamaruddin, N.A., Mohamed Ismail, N.A., Razalli, N.H., Gnanou, J.V., et al. (2020) Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential. Frontiers in Cellular and Infection Microbiology, 10, Article 188. [Google Scholar] [CrossRef] [PubMed]
[24] 蔡婧. 甲状腺功能与代谢综合征及甲功相关基因多态性的关联性研究[D]: [博士学位论文]. 西安: 第四军医大学, 2017.
[25] Jia, M., Wu, Y., Lin, B., Shi, Y., Zhang, Q., Lin, Y., et al. (2019) Meta‐Analysis of the Association between Maternal Subclinical Hypothyroidism and Gestational Diabetes Mellitus. International Journal of Gynecology & Obstetrics, 144, 239-247. [Google Scholar] [CrossRef] [PubMed]
[26] 曾玮玮, 王彦钧, 王静, 等. 肠易激综合征患者神经内分泌轴功能和血糖变化及其与病情严重程度的相关性研究[J]. 重庆医学, 2022, 51(2): 214-218.
[27] Turunen, S., Vääräsmäki, M., Männistö, T., Hartikainen, A., Lahesmaa-Korpinen, A., Gissler, M., et al. (2019) Pregnancy and Perinatal Outcome among Hypothyroid Mothers: A Population-Based Cohort Study. Thyroid, 29, 135-141. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, Y., Sun, X., Tao, J., Song, B., Wu, W., Li, Y., et al. (2022) Gestational Diabetes Mellitus Is Associated with Antenatal Hypercoagulability and Hyperfibrinolysis: A Case Control Study of Chinese Women. The Journal of Maternal-Fetal & Neonatal Medicine, 35, 2995-2998. [Google Scholar] [CrossRef] [PubMed]
[29] Saucedo, R., Ortega-Camarillo, C., Ferreira-Hermosillo, A., Díaz-Velázquez, M.F., Meixueiro-Calderón, C. and Valencia-Ortega, J. (2023) Role of Oxidative Stress and Inflammation in Gestational Diabetes Mellitus. Antioxidants, 12, Article 1812. [Google Scholar] [CrossRef] [PubMed]
[30] Zhu, D., Ma, D., Wu, M., Sun, J., He, T., Qin, Y., et al. (2025) Oxylipins from N-6 and N-3 Fatty Acids Modulate Uterine Decidualization. Biology of Reproduction, 2025, ioaf256. [Google Scholar] [CrossRef